| Manufacturing | Contract manufacturing of pharmaceutical finished formulations including injectables, tablets, capsules, and pellets. | State-of-the-art facilities with government licenses ensuring regulatory compliance and quality. | B2B pharmaceutical companies requiring contract manufacturing services. | Specialized injectables and ready-to-fill pellets. | 28 | 50 | Sales from manufacturing and formulation services to pharmaceutical clients. | Contract-based direct sales and service fees. | Innovation in drug delivery formulations and expanding manufacturing capacity. | |
| Trading | Trading of pharmaceutical products and formulations complementary to manufacturing operations. | Established supplier relationships and market reach. | Pharmacies, distributors, and healthcare providers (B2B/B2C mix). | Trade of niche pharmaceutical products. | 29 | 50 | Sales revenue from trade of medicines and related products. | Direct sales with inventory turnover model. | Growing demand for quality pharmaceutical products and supply chain optimization. | |
